New Under-the-Tongue painkiller could speed up surgery recovery
NCT ID NCT07624006
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new under-the-tongue painkiller (sublingual sufentanil) to standard morphine pills for managing pain after surgery. The goal is to see if the new drug helps patients recover their health faster. About 1150 adults having surgery will take part, receiving either the new drug or morphine as needed for up to three days after their operation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sublingual sufentanil (Dzuveo)
- What this could lead to
- If it works, this could offer a faster-acting pain relief option after surgery, potentially improving recovery quality.
- What could go wrong
- This is a Phase 4 trial, so the drug is already approved. However, it may not prove significantly better than morphine, and side effects like nausea or dizziness are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can patients safely dispense their own pain medicine after surgery?
- Can a VR headset calm nerves before surgery?
- Can a less invasive nerve block match the gold standard for chest surgery pain?
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- One injection or many? a test to ease breast surgery pain
- One injection vs. two: a new approach to shoulder surgery pain?